Federal Trade Commission Should Allow CVS Acquisition Of Caremark With Conditions Op-Ed Says
The Federal Trade Commission "should probably not stand in the way" of the $21 billion acquisition of pharmacy benefit manager Caremark Rx by pharmacy chain CVS Washington Post columnist Steven Pearlstein writes in an opinion piece. [click link for full article]
posted by Smile Community @ 9:54 PM
0 Comments:
Post a Comment
<< Home